Clinical Trial Update: FES-Rowing Versus Zoledronic Acid to Improve Bone Health in Spinal Cord Injury (SCI) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial comparing functional electrical stimulation (FES) rowing versus zoledronic acid for bone health in spinal cord injury-related osteoporosis was…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• FES-Rowing
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Antonio Lazzari | Conditions: Osteoporosis | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2016-03-10